glp-1 news today october 2025 RA prescription trends: January 2019 – December GLP-1s for Weight Loss: What

10.5301/ejo.5001011 145 PrinzJ.MaffulliN.FuestM.WalterP.HildebrandF.MiglioriniF

+++The effect of GLP-1R agonists on brain mechanism is more than 75% (relative to the control group and the AD group without GLP-1R agonists)

Dose conversion strategies that actually work No official conversion ratio exists between tirzepatide and semaglutide doses

New data on Hengrui Pharma and Kailera Therapeutics investigational oral GLP-1 have validated the late-stage weight loss asset and paved the road for a regulatory submission in China, but analysts pointed to high rates of nausea and vomiting that could challenge the ongoing U.S

Despite nine AOMs being currently approved for the treatment of obesity, limited clinical trial evidence in older adults predominantly focuses on incretin therapy with glucagon-like peptide-1 receptor agonists (liraglutide, semaglutide, and tirzepatide)

My favorite liver-supporting supplement